Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2004 3
2005 2
2006 6
2007 2
2008 11
2009 9
2010 6
2011 4
2012 7
2013 12
2014 13
2015 14
2016 8
2017 10
2018 8
2019 13
2020 6
2021 7
2022 9
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan controls hemolysis in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
Wong RSM, Navarro-Cabrera JR, Comia NS, Goh YT, Idrobo H, Kongkabpan D, Gómez-Almaguer D, Al-Adhami M, Ajayi T, Alvarenga P, Savage J, Deschatelets P, Francois C, Grossi F, Dumagay T. Wong RSM, et al. Among authors: alvarenga p. Blood Adv. 2023 Jun 13;7(11):2468-2478. doi: 10.1182/bloodadvances.2022009129. Blood Adv. 2023. PMID: 36848639 Free PMC article. Clinical Trial.
DBS for Obesity.
Franco R, Fonoff ET, Alvarenga P, Lopes AC, Miguel EC, Teixeira MJ, Damiani D, Hamani C. Franco R, et al. Among authors: alvarenga p. Brain Sci. 2016 Jul 18;6(3):21. doi: 10.3390/brainsci6030021. Brain Sci. 2016. PMID: 27438859 Free PMC article. Review.
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.
Reis G, Dos Santos Moreira Silva EA, Medeiros Silva DC, Thabane L, de Souza Campos VH, Ferreira TS, Quirino Dos Santos CV, Ribeiro Nogueira AM, Figueiredo Guimaraes Almeida AP, Cançado Monteiro Savassi L, de Figueiredo Neto AD, Bitarães C, Cruz Milagres A, Diniz Callegari E, Campos Simplicio MI, Barra Ribeiro L, Oliveira R, Harari O, Wilson LA, Forrest JI, Ruton H, Sprague S, McKay P, Guo CM, Guyatt GH, Rayner CR, Boulware DR, Ezer N, Lee TC, McDonald EG, Bafadhel M, Butler C, Rodrigues Silva J, Dybul M, Mills EJ; TOGETHER Investigators. Reis G, et al. Ann Intern Med. 2023 May;176(5):667-675. doi: 10.7326/M22-3305. Epub 2023 Apr 18. Ann Intern Med. 2023. PMID: 37068273 Free PMC article. Clinical Trial.
Gender differences in obsessive-compulsive disorder: a literature review.
Mathis MA, Alvarenga Pd, Funaro G, Torresan RC, Moraes I, Torres AR, Zilberman ML, Hounie AG. Mathis MA, et al. Among authors: alvarenga pd. Braz J Psychiatry. 2011 Dec;33(4):390-9. doi: 10.1590/s1516-44462011000400014. Braz J Psychiatry. 2011. PMID: 22189930 Free article. Review.
Neurologic Manifestations of Noncongenital Zika Virus in Children.
Bentes AA, Crispim APC, Marinho PES, Viegas ECC, Loutfi KS, Guedes I, Araujo ST, Alvarenga AM, Campos E Silva LM, Santos MA, Batista AK, Alvarenga PP, Candiani TMS, Kroon EG, de Castro Romanelli RM. Bentes AA, et al. Among authors: alvarenga pp. J Pediatr. 2021 Oct;237:298-301.e1. doi: 10.1016/j.jpeds.2021.06.074. Epub 2021 Jul 1. J Pediatr. 2021. PMID: 34216632
Risk factors for obsessive-compulsive symptoms. Follow-up of a community-based youth cohort.
Macul Ferreira de Barros P, do Rosário MC, Szejko N, Polga N, Requena GL, Ravagnani B, Fatori D, Batistuzzo MC, Hoexter MQ, Rohde LA, Polanczyk GV, Leckman JF, Miguel EC, de Alvarenga PG. Macul Ferreira de Barros P, et al. Among authors: de alvarenga pg. Eur Child Adolesc Psychiatry. 2021 Jan;30(1):89-104. doi: 10.1007/s00787-020-01495-7. Epub 2020 Feb 19. Eur Child Adolesc Psychiatry. 2021. PMID: 32076869
134 results